2 Hot Stocks to Watch: Shaw Communications, Inc. (NYSE:SJR), Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)

Shaw Communications, Inc. (NYSE:SJR)

The shares of Shaw Communications, Inc. (NYSE:SJR) started off the last trading session with the price of $19.02 while closing the day with the price of $18.86. The shares of Shaw Communications, Inc. (NYSE:SJR) Fell -1% with the Loss of -0.16 points.

The shares of Shaw Communications, Inc. (NYSE:SJR) traded with the day volume of 2.21 Million shares whereas its average trading volume is 615.16 Million.

While analyzing the past performance of the stock we can see that the shares of Shaw Communications, Inc. (NYSE:SJR) Loss -2.83% in the last week while Falling -7.68% in the last month. Past quarter performance shows the red light with -19.19%. The semi-annual and annual performance shows -16.66% and -8.22% respectively.

Some critical values of the shares of Shaw Communications, Inc. (NYSE:SJR) to be discussed here are: the beta which shows the value at 0.96 while Average True Range of Shaw Communications, Inc. (NYSE:SJR) demonstrate the value at 0.35. The weekly and monthly volatility of the shares of Shaw Communications, Inc. (NYSE:SJR) are indicated at 1.89% and 1.74%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 29.76.

While studying the financial position of the shares of Shaw Communications, Inc. (NYSE:SJR), we can see that the Market capitalization of the company is at 9.58 Billion. The shares outstanding for the company is 507.72 Million and the shares float stands at 441.65 Million. The income of the company stand at 445.1 Million while the sales stand at 3.7 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.9, Price to Earnings or P/E is at 20.93, Price to Sales P/S show the value of 2.59, the Return on Asset ROA stood at 0.058 and the Return on Equity ROE depicted at 0.152 while Return on Investment ROI is at 0.08.


Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) started its previous trading session at $26.48 and closed at $27.1 showing a Rise of 2.46 Percent.

The Company traded with an average Volume of 1.04 Million whereas, its Day Volume stood at 2.2 Million.

Looking at the performance of the stock, Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Loss -2.13% in the last week in its shares price and -22.66% in the last month. Quarterly performance shows a red of -18.74 Percent while Semi-Annual and Annual performances shows a 31.94 and 54.95 percent respectively.

Beta for Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) stands at 1.59 while the ATR (average true range) is at 2.1. The Stock’s Weekly and Monthly Volatility is 6.99% and 7.49% respectively showing a RSI value of 43.76.

While studying the financial position of the shares of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), we can see that the Market capitalization of the company is at 680.21 Million. The shares outstanding for the company is 25.1 Million and the shares float stands at 24.61 Million.

The Company generated an income of -114400000 and the sales of 600000 in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-5.04 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 1133.68 respectively.

The Return on Assets stands at -0.595, ROE shows a value of -0.953 and ROI for Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) is -0.659 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment